🇸🇬 Zynlonta in Singapore

Zynlonta (LONCASTUXIMAB) regulatory status in Singapore.

Marketing authorisation

HSA

  • Status: likely_approved

Zynlonta in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in Singapore

Frequently asked questions

Is Zynlonta approved in Singapore?

Yes. HSA has authorised it.

Who is the marketing authorisation holder for Zynlonta in Singapore?

ADC Therapeutics SA is the originator. The local marketing authorisation holder may differ — check the official source linked above.